APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dexlansoprazole for Injection

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Dexlansoprazole for Injection Market Outlook and Growth Opportunities 2026

30 December 2025193 pages

Choose your research edition.

Industry ResearchDexlansoprazole for Injection Industry Research Report 2026108 pages · $2,950 USDIndustry Growth & TrendsGlobal Dexlansoprazole for Injection Industry Growth and Trends Forecast to 203276 pages · $3,450 USDMarket StructureGlobal Dexlansoprazole for Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032171 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dexlansoprazole for Injection Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Dexlansoprazole for Injection Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Dexlansoprazole for Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Dexlansoprazole for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Dexlansoprazole for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Dexlansoprazole for Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Dexlansoprazole for Injection market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Dexlansoprazole for Injection market include Sailong Pharmaceutical, Jiangsu Aosaikang Pharmaceutical and Sunho Biologics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Dexlansoprazole for Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Dexlansoprazole for Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Dexlansoprazole for Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Dexlansoprazole for Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Dexlansoprazole for Injection Segment by Company

Sailong Pharmaceutical

Jiangsu Aosaikang Pharmaceutical

Sunho Biologics

Dexlansoprazole for Injection Segment by Type

Original Drug

Generic Drug

Dexlansoprazole for Injection Segment by Application

Hospital

Clinic

Others

Dexlansoprazole for Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Dexlansoprazole for Injection status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Dexlansoprazole for Injection market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Dexlansoprazole for Injection significant trends, drivers, influence factors in global and regions.

6. To analyze Dexlansoprazole for Injection competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dexlansoprazole for Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dexlansoprazole for Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dexlansoprazole for Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Dexlansoprazole for Injection market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Dexlansoprazole for Injection industry.

Chapter 3: Detailed analysis of Dexlansoprazole for Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Dexlansoprazole for Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Dexlansoprazole for Injection in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Dexlansoprazole for Injection Industry Trends Table 2. Dexlansoprazole for Injection Industry Drivers Table 3. Dexlansoprazole for Injection Industry Opportunities and Challenges Table 4. Dexlansoprazole for Injection Industry Restraints Table 5. Global Dexlansoprazole for Injection Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Dexlansoprazole for Injection Revenue Share by Company (2021-2026) Table 7. Global Dexlansoprazole for Injection Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Dexlansoprazole for Injection Sales Volume Share by Company (2021-2026) Table 9. Global Dexlansoprazole for Injection Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Dexlansoprazole for Injection Company Ranking, (2024-2026) & (USD Million) Table 11. Global Dexlansoprazole for Injection Key Company Manufacturing Base & Headquarters Table 12. Global Dexlansoprazole for Injection Company, Product Type & Application Table 13. Global Dexlansoprazole for Injection Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Dexlansoprazole for Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Original Drug Table 18. Significant Companies of Generic Drug Table 19. Global Dexlansoprazole for Injection Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Dexlansoprazole for Injection Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Dexlansoprazole for Injection Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Dexlansoprazole for Injection Sales Volume Share by Type (2021-2026) Table 23. Global Dexlansoprazole for Injection Sales Volume Share by Type (2027-2032) Table 24. Global Dexlansoprazole for Injection Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Dexlansoprazole for Injection Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Dexlansoprazole for Injection Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Dexlansoprazole for Injection Sales Value Share by Type (2021-2026) Table 28. Global Dexlansoprazole for Injection Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Others Table 32. Global Dexlansoprazole for Injection Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Dexlansoprazole for Injection Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Dexlansoprazole for Injection Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Dexlansoprazole for Injection Sales Volume Share by Application (2021-2026) Table 36. Global Dexlansoprazole for Injection Sales Volume Share by Application (2027-2032) Table 37. Global Dexlansoprazole for Injection Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Dexlansoprazole for Injection Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Dexlansoprazole for Injection Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Dexlansoprazole for Injection Sales Value Share by Application (2021-2026) Table 41. Global Dexlansoprazole for Injection Sales Value Share by Application (2027-2032) Table 42. Global Dexlansoprazole for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Dexlansoprazole for Injection Sales by Region (2021-2026) & (K Units) Table 44. Global Dexlansoprazole for Injection Sales Market Share by Region (2021-2026) Table 45. Global Dexlansoprazole for Injection Sales by Region (2027-2032) & (K Units) Table 46. Global Dexlansoprazole for Injection Sales Market Share by Region (2027-2032) Table 47. Global Dexlansoprazole for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Dexlansoprazole for Injection Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Dexlansoprazole for Injection Sales Value Share by Region (2021-2026) Table 50. Global Dexlansoprazole for Injection Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Dexlansoprazole for Injection Sales Value Share by Region (2027-2032) Table 52. Global Dexlansoprazole for Injection Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Dexlansoprazole for Injection Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Dexlansoprazole for Injection Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Dexlansoprazole for Injection Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Dexlansoprazole for Injection Sales by Country (2021-2026) & (K Units) Table 57. Global Dexlansoprazole for Injection Sales Market Share by Country (2021-2026) Table 58. Global Dexlansoprazole for Injection Sales by Country (2027-2032) & (K Units) Table 59. Global Dexlansoprazole for Injection Sales Market Share by Country (2027-2032) Table 60. Global Dexlansoprazole for Injection Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Dexlansoprazole for Injection Sales Value Market Share by Country (2021-2026) Table 62. Global Dexlansoprazole for Injection Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Dexlansoprazole for Injection Sales Value Market Share by Country (2027-2032) Table 64. Sailong Pharmaceutical Company Information Table 65. Sailong Pharmaceutical Business Overview Table 66. Sailong Pharmaceutical Dexlansoprazole for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Sailong Pharmaceutical Dexlansoprazole for Injection Product Portfolio Table 68. Sailong Pharmaceutical Recent Development Table 69. Jiangsu Aosaikang Pharmaceutical Company Information Table 70. Jiangsu Aosaikang Pharmaceutical Business Overview Table 71. Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Product Portfolio Table 73. Jiangsu Aosaikang Pharmaceutical Recent Development Table 74. Sunho Biologics Company Information Table 75. Sunho Biologics Business Overview Table 76. Sunho Biologics Dexlansoprazole for Injection Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Sunho Biologics Dexlansoprazole for Injection Product Portfolio Table 78. Sunho Biologics Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. Dexlansoprazole for Injection Distributors List Table 82. Dexlansoprazole for Injection Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. Dexlansoprazole for Injection Product Image Figure 2. Global Dexlansoprazole for Injection Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dexlansoprazole for Injection Sales Value (2021-2032) & (US$ Million) Figure 4. Global Dexlansoprazole for Injection Sales (2021-2032) & (K Units) Figure 5. Global Dexlansoprazole for Injection Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Dexlansoprazole for Injection Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Original Drug Image Figure 10. Generic Drug Image Figure 11. Global Dexlansoprazole for Injection Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Dexlansoprazole for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Dexlansoprazole for Injection Sales Volume Share by Type (2021-2032) Figure 14. Global Dexlansoprazole for Injection Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Dexlansoprazole for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Dexlansoprazole for Injection Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Others Image Figure 20. Global Dexlansoprazole for Injection Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Dexlansoprazole for Injection Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Dexlansoprazole for Injection Sales Volume Share by Application (2021-2032) Figure 23. Global Dexlansoprazole for Injection Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Dexlansoprazole for Injection Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Dexlansoprazole for Injection Sales Value Share by Application (2021-2032) Figure 26. Global Dexlansoprazole for Injection Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Dexlansoprazole for Injection Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Dexlansoprazole for Injection Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Dexlansoprazole for Injection Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Dexlansoprazole for Injection Sales Value (2021-2032) & (US$ Million) Figure 31. North America Dexlansoprazole for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Dexlansoprazole for Injection Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Dexlansoprazole for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Dexlansoprazole for Injection Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Dexlansoprazole for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Dexlansoprazole for Injection Sales Value (2021-2032) & (US$ Million) Figure 37. South America Dexlansoprazole for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Dexlansoprazole for Injection Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Dexlansoprazole for Injection Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Dexlansoprazole for Injection Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Dexlansoprazole for Injection Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Original Drug
  • Generic Drug
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Sailong Pharmaceutical
  • Jiangsu Aosaikang Pharmaceutical
  • Sunho Biologics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Dexlansoprazole for Injection Sales Value (2021-2032)
  4. 1.2.2 Global Dexlansoprazole for Injection Sales Volume (2021-2032)
  5. 1.2.3 Global Dexlansoprazole for Injection Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Dexlansoprazole for Injection Market Dynamics
  1. 2.1 Dexlansoprazole for Injection Industry Trends
  2. 2.2 Dexlansoprazole for Injection Industry Drivers
  3. 2.3 Dexlansoprazole for Injection Industry Opportunities and Challenges
  4. 2.4 Dexlansoprazole for Injection Industry Restraints
3 Dexlansoprazole for Injection Market by Company
  1. 3.1 Global Dexlansoprazole for Injection Company Revenue Ranking in 2025
  2. 3.2 Global Dexlansoprazole for Injection Revenue by Company (2021-2026)
  3. 3.3 Global Dexlansoprazole for Injection Sales Volume by Company (2021-2026)
  4. 3.4 Global Dexlansoprazole for Injection Average Price by Company (2021-2026)
  5. 3.5 Global Dexlansoprazole for Injection Company Ranking (2024-2026)
  6. 3.6 Global Dexlansoprazole for Injection Company Manufacturing Base and Headquarters
  7. 3.7 Global Dexlansoprazole for Injection Company Product Type and Application
  8. 3.8 Global Dexlansoprazole for Injection Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Dexlansoprazole for Injection Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Dexlansoprazole for Injection Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Dexlansoprazole for Injection Market by Type
  1. 4.1 Dexlansoprazole for Injection Type Introduction
  2. 4.1.1 Original Drug
  3. 4.1.2 Generic Drug
  4. 4.2 Global Dexlansoprazole for Injection Sales Volume by Type
  5. 4.2.1 Global Dexlansoprazole for Injection Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Dexlansoprazole for Injection Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Dexlansoprazole for Injection Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Dexlansoprazole for Injection Sales Value by Type
  9. 4.3.1 Global Dexlansoprazole for Injection Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Dexlansoprazole for Injection Sales Value by Type (2021-2032)
  11. 4.3.3 Global Dexlansoprazole for Injection Sales Value Share by Type (2021-2032)
5 Dexlansoprazole for Injection Market by Application
  1. 5.1 Dexlansoprazole for Injection Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Dexlansoprazole for Injection Sales Volume by Application
  6. 5.2.1 Global Dexlansoprazole for Injection Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dexlansoprazole for Injection Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Dexlansoprazole for Injection Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Dexlansoprazole for Injection Sales Value by Application
  10. 5.3.1 Global Dexlansoprazole for Injection Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Dexlansoprazole for Injection Sales Value by Application (2021-2032)
  12. 5.3.3 Global Dexlansoprazole for Injection Sales Value Share by Application (2021-2032)
6 Dexlansoprazole for Injection Regional Sales and Value Analysis
  1. 6.1 Global Dexlansoprazole for Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Dexlansoprazole for Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Dexlansoprazole for Injection Sales by Region: 2021-2026
  4. 6.2.2 Global Dexlansoprazole for Injection Sales by Region (2027-2032)
  5. 6.3 Global Dexlansoprazole for Injection Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Dexlansoprazole for Injection Sales Value by Region (2021-2032)
  7. 6.4.1 Global Dexlansoprazole for Injection Sales Value by Region: 2021-2026
  8. 6.4.2 Global Dexlansoprazole for Injection Sales Value by Region (2027-2032)
  9. 6.5 Global Dexlansoprazole for Injection Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Dexlansoprazole for Injection Sales Value (2021-2032)
  12. 6.6.2 North America Dexlansoprazole for Injection Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Dexlansoprazole for Injection Sales Value (2021-2032)
  15. 6.7.2 Europe Dexlansoprazole for Injection Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Dexlansoprazole for Injection Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Dexlansoprazole for Injection Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Dexlansoprazole for Injection Sales Value (2021-2032)
  21. 6.9.2 South America Dexlansoprazole for Injection Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Dexlansoprazole for Injection Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Dexlansoprazole for Injection Sales Value Share by Country, 2025 VS 2032
7 Dexlansoprazole for Injection Country-level Sales and Value Analysis
  1. 7.1 Global Dexlansoprazole for Injection Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Dexlansoprazole for Injection Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Dexlansoprazole for Injection Sales by Country (2021-2032)
  4. 7.3.1 Global Dexlansoprazole for Injection Sales by Country (2021-2026)
  5. 7.3.2 Global Dexlansoprazole for Injection Sales by Country (2027-2032)
  6. 7.4 Global Dexlansoprazole for Injection Sales Value by Country (2021-2032)
  7. 7.4.1 Global Dexlansoprazole for Injection Sales Value by Country (2021-2026)
  8. 7.4.2 Global Dexlansoprazole for Injection Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Dexlansoprazole for Injection Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Dexlansoprazole for Injection Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Dexlansoprazole for Injection Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Sailong Pharmaceutical
  2. 8.1.1 Sailong Pharmaceutical Company Information
  3. 8.1.2 Sailong Pharmaceutical Business Overview
  4. 8.1.3 Sailong Pharmaceutical Dexlansoprazole for Injection Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Sailong Pharmaceutical Dexlansoprazole for Injection Product Portfolio
  6. 8.1.5 Sailong Pharmaceutical Recent Developments
  7. 8.2 Jiangsu Aosaikang Pharmaceutical
  8. 8.2.1 Jiangsu Aosaikang Pharmaceutical Company Information
  9. 8.2.2 Jiangsu Aosaikang Pharmaceutical Business Overview
  10. 8.2.3 Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Jiangsu Aosaikang Pharmaceutical Dexlansoprazole for Injection Product Portfolio
  12. 8.2.5 Jiangsu Aosaikang Pharmaceutical Recent Developments
  13. 8.3 Sunho Biologics
  14. 8.3.1 Sunho Biologics Company Information
  15. 8.3.2 Sunho Biologics Business Overview
  16. 8.3.3 Sunho Biologics Dexlansoprazole for Injection Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sunho Biologics Dexlansoprazole for Injection Product Portfolio
  18. 8.3.5 Sunho Biologics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Dexlansoprazole for Injection Value Chain Analysis
  2. 9.1.1 Dexlansoprazole for Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Dexlansoprazole for Injection Sales Mode & Process
  6. 9.2 Dexlansoprazole for Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Dexlansoprazole for Injection Distributors
  9. 9.2.3 Dexlansoprazole for Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst